Cargando…

Lung cancer risk score for ever and never smokers in China

BACKGROUND: Most lung cancer risk prediction models were developed in European and North‐American cohorts of smokers aged ≥ 55 years, while less is known about risk profiles in Asia, especially for never smokers or individuals aged < 50 years. Hence, we aimed to develop and validate a lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zhimin, Lv, Jun, Zhu, Meng, Yu, Canqing, Ma, Hongxia, Jin, Guangfu, Guo, Yu, Bian, Zheng, Yang, Ling, Chen, Yiping, Chen, Zhengming, Hu, Zhibin, Li, Liming, Shen, Hongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397566/
https://www.ncbi.nlm.nih.gov/pubmed/37410540
http://dx.doi.org/10.1002/cac2.12463
_version_ 1785083941805359104
author Ma, Zhimin
Lv, Jun
Zhu, Meng
Yu, Canqing
Ma, Hongxia
Jin, Guangfu
Guo, Yu
Bian, Zheng
Yang, Ling
Chen, Yiping
Chen, Zhengming
Hu, Zhibin
Li, Liming
Shen, Hongbing
author_facet Ma, Zhimin
Lv, Jun
Zhu, Meng
Yu, Canqing
Ma, Hongxia
Jin, Guangfu
Guo, Yu
Bian, Zheng
Yang, Ling
Chen, Yiping
Chen, Zhengming
Hu, Zhibin
Li, Liming
Shen, Hongbing
author_sort Ma, Zhimin
collection PubMed
description BACKGROUND: Most lung cancer risk prediction models were developed in European and North‐American cohorts of smokers aged ≥ 55 years, while less is known about risk profiles in Asia, especially for never smokers or individuals aged < 50 years. Hence, we aimed to develop and validate a lung cancer risk estimate tool for ever and never smokers across a wide age range. METHODS: Based on the China Kadoorie Biobank cohort, we first systematically selected the predictors and explored the nonlinear association of predictors with lung cancer risk using restricted cubic splines. Then, we separately developed risk prediction models to construct a lung cancer risk score (LCRS) in 159,715 ever smokers and 336,526 never smokers. The LCRS was further validated in an independent cohort over a median follow‐up of 13.6 years, consisting of 14,153 never smokers and 5,890 ever smokers. RESULTS: A total of 13 and 9 routinely available predictors were identified for ever and never smokers, respectively. Of these predictors, cigarettes per day and quit years showed nonlinear associations with lung cancer risk (P (non‐linear) < 0.001). The curve of lung cancer incidence increased rapidly above 20 cigarettes per day and then was relatively flat until approximately 30 cigarettes per day. We also observed that lung cancer risk declined sharply within the first 5 years of quitting, and then continued to decrease but at a slower rate in the subsequent years. The 6‐year area under the receiver operating curve for the ever and never smokers’ models were respectively 0.778 and 0.733 in the derivation cohort, and 0.774 and 0.759 in the validation cohort. In the validation cohort, the 10‐year cumulative incidence of lung cancer was 0.39% and 2.57% for ever smokers with low (< 166.2) and intermediate‐high LCRS (≥ 166.2), respectively. Never smokers with a high LCRS (≥ 21.2) had a higher 10‐year cumulative incidence rate than those with a low LCRS (< 21.2; 1.05% vs. 0.22%). An online risk evaluation tool (LCKEY; http://ccra.njmu.edu.cn/lckey/web) was developed to facilitate the use of LCRS. CONCLUSIONS: The LCRS can be an effective risk assessment tool designed for ever and never smokers aged 30 to 80 years.
format Online
Article
Text
id pubmed-10397566
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-103975662023-08-04 Lung cancer risk score for ever and never smokers in China Ma, Zhimin Lv, Jun Zhu, Meng Yu, Canqing Ma, Hongxia Jin, Guangfu Guo, Yu Bian, Zheng Yang, Ling Chen, Yiping Chen, Zhengming Hu, Zhibin Li, Liming Shen, Hongbing Cancer Commun (Lond) Original Articles BACKGROUND: Most lung cancer risk prediction models were developed in European and North‐American cohorts of smokers aged ≥ 55 years, while less is known about risk profiles in Asia, especially for never smokers or individuals aged < 50 years. Hence, we aimed to develop and validate a lung cancer risk estimate tool for ever and never smokers across a wide age range. METHODS: Based on the China Kadoorie Biobank cohort, we first systematically selected the predictors and explored the nonlinear association of predictors with lung cancer risk using restricted cubic splines. Then, we separately developed risk prediction models to construct a lung cancer risk score (LCRS) in 159,715 ever smokers and 336,526 never smokers. The LCRS was further validated in an independent cohort over a median follow‐up of 13.6 years, consisting of 14,153 never smokers and 5,890 ever smokers. RESULTS: A total of 13 and 9 routinely available predictors were identified for ever and never smokers, respectively. Of these predictors, cigarettes per day and quit years showed nonlinear associations with lung cancer risk (P (non‐linear) < 0.001). The curve of lung cancer incidence increased rapidly above 20 cigarettes per day and then was relatively flat until approximately 30 cigarettes per day. We also observed that lung cancer risk declined sharply within the first 5 years of quitting, and then continued to decrease but at a slower rate in the subsequent years. The 6‐year area under the receiver operating curve for the ever and never smokers’ models were respectively 0.778 and 0.733 in the derivation cohort, and 0.774 and 0.759 in the validation cohort. In the validation cohort, the 10‐year cumulative incidence of lung cancer was 0.39% and 2.57% for ever smokers with low (< 166.2) and intermediate‐high LCRS (≥ 166.2), respectively. Never smokers with a high LCRS (≥ 21.2) had a higher 10‐year cumulative incidence rate than those with a low LCRS (< 21.2; 1.05% vs. 0.22%). An online risk evaluation tool (LCKEY; http://ccra.njmu.edu.cn/lckey/web) was developed to facilitate the use of LCRS. CONCLUSIONS: The LCRS can be an effective risk assessment tool designed for ever and never smokers aged 30 to 80 years. John Wiley and Sons Inc. 2023-07-06 /pmc/articles/PMC10397566/ /pubmed/37410540 http://dx.doi.org/10.1002/cac2.12463 Text en © 2023 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Ma, Zhimin
Lv, Jun
Zhu, Meng
Yu, Canqing
Ma, Hongxia
Jin, Guangfu
Guo, Yu
Bian, Zheng
Yang, Ling
Chen, Yiping
Chen, Zhengming
Hu, Zhibin
Li, Liming
Shen, Hongbing
Lung cancer risk score for ever and never smokers in China
title Lung cancer risk score for ever and never smokers in China
title_full Lung cancer risk score for ever and never smokers in China
title_fullStr Lung cancer risk score for ever and never smokers in China
title_full_unstemmed Lung cancer risk score for ever and never smokers in China
title_short Lung cancer risk score for ever and never smokers in China
title_sort lung cancer risk score for ever and never smokers in china
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397566/
https://www.ncbi.nlm.nih.gov/pubmed/37410540
http://dx.doi.org/10.1002/cac2.12463
work_keys_str_mv AT mazhimin lungcancerriskscoreforeverandneversmokersinchina
AT lvjun lungcancerriskscoreforeverandneversmokersinchina
AT zhumeng lungcancerriskscoreforeverandneversmokersinchina
AT yucanqing lungcancerriskscoreforeverandneversmokersinchina
AT mahongxia lungcancerriskscoreforeverandneversmokersinchina
AT jinguangfu lungcancerriskscoreforeverandneversmokersinchina
AT guoyu lungcancerriskscoreforeverandneversmokersinchina
AT bianzheng lungcancerriskscoreforeverandneversmokersinchina
AT yangling lungcancerriskscoreforeverandneversmokersinchina
AT chenyiping lungcancerriskscoreforeverandneversmokersinchina
AT chenzhengming lungcancerriskscoreforeverandneversmokersinchina
AT huzhibin lungcancerriskscoreforeverandneversmokersinchina
AT liliming lungcancerriskscoreforeverandneversmokersinchina
AT shenhongbing lungcancerriskscoreforeverandneversmokersinchina